Lung cancer is a type of cancer that originates in the cells of the lungs, causing uncontrolled cell growth and the formation of tumours. It is a leading cause of cancer-related deaths globally and can affect both smokers and non-smokers, although smoking significantly increases the risk. Lung cancer is classified into two main types: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), each with its own characteristics and treatment options.
Last updated on : 07 Nov, 2024
Read time : 16 mins
Lung cancer is a serious and life-threatening condition that develops when cells in the lungs grow abnormally and form tumours. It is one of the most common types of cancer and a leading cause of cancer deaths worldwide. While smoking is a major risk factor for lung cancer, it can also occur in non-smokers. Understanding the types, symptoms, and treatment options for lung cancer is crucial for early detection and effective management of the disease.
Lung cancer, also known as pulmonary carcinoma, is a type of cancer that originates in the lungs. It occurs when cells in the lung tissue grow and divide uncontrollably, leading to the formation of tumours. These tumours can interfere with the normal functioning of the lungs, including breathing. Without proper treatment, the tumours can spread throughout the lungs, impairing their function and eventually metastasising to other parts of the body. The severity and prognosis of lung cancer depend on various factors, including the type and stage of the disease.
Category | Details |
Also Referred as | Bronchogenic carcinoma, oat cell carcinoma |
Commonly Occurs In | Outer lung region, central lung, any part of the lung |
Affected Organ | Lungs |
Type | Adenocarcinoma, Squamous cell carcinoma, Large cell carcinoma, Small cell carcinoma, Combined small cell carcinoma |
Common Signs | Coughing, Hoarseness, Weight loss, Weakness |
Consulting Specialist | Pulmonologist, oncologist |
Treatement Procedures | Surgery, Chemotherapy, Radiation, Immunotherapy, Targeted medications |
Managed By | Radiotherapy, Immunotherapy, Chemotherapy, Targeted medication therapy, Surgery (Wedge resection, Segmental resection & Pneumonectomy ) |
Mimiciking Condition | Pneumonia, bronchitis |
Lung cancer is primarily categorised into two types based on the size and appearance of the malignant cells under a microscope. These include:
Small cell lung cancer (SCLC): SCLC is characterised by its rapid growth and spread. It typically originates near the centre of the lungs, in the major airways, and quickly metastasises to other body parts. Small cell carcinoma is almost exclusively associated with smoking and tends to respond well to chemotherapy and radiation therapy.
Non-small cell lung cancer (NSCLC): NSCLC is the most common type of lung cancer. It grows more slowly than SCLC and is further classified into subtypes such as:
Adenocarcinoma: This subtype develops in the epithelial cells that line the airways and produce mucus. It is often found in the outer regions of the lungs.
Squamous cell carcinoma: Originating in the flat cells that cover the surface of the airways, squamous cell carcinoma is frequently linked to smoking and typically develops near the centre of the lungs.
Large cell carcinoma: This subtype can appear in any part of the lung and is known for its rapid growth and spread compared to adenocarcinoma and squamous cell carcinoma.
Some of the early symptoms of lung cancer include:
Persistent cough
Shortness of breath or wheezing
Chest pain or discomfort
Changes in your voice, such as hoarseness
Frequent lung infections, such as bronchitis or pneumonia
Unexplained weight loss and changes in appetite
In its early stages, lung cancer often does not present with noticeable symptoms. However, as the disease progresses, various symptoms may develop, including:
Persistent cough: Lung cancer often begins with a cough that doesn’t go away. This cough can become more severe over time, potentially indicating the presence of a tumour or irritation in the lungs.
Coughing up blood: Haemoptysis, or coughing up blood, can range from small specks to larger amounts and should be evaluated by a doctor without delay.
Shortness of breath: Many individuals with lung cancer experience shortness of breath, which can occur even during light physical activity. This symptom may develop as tumours obstruct airways or affect lung function.
Chest pain: Patients may describe this pain as sharp or dull, and it might worsen with deep breaths or during coughing, often signalling the involvement of surrounding tissues.
Unexplained weight loss: This symptom can result from a combination of reduced appetite and the increased energy demands placed on the body by the disease itself.
Fatigue: Patients may describe fatigue as an overwhelming tiredness that is not relieved by rest, significantly affecting their daily activities and overall quality of life.
Recurrent respiratory infections: Individuals with lung cancer may experience frequent respiratory infections, such as bronchitis or pneumonia, due to blockages in the airways or compromised lung function.
Hoarseness or voice changes: Some patients may experience hoarseness due to cancer affecting nearby structures, which can signal disease progression.
Lung cancer stages are determined based on the size and spread of the tumour. The two main types of lung cancer, small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), have different staging systems.
The small cell lung cancer stages include:
Limited stage: The cancer is confined to one lung and possibly to the lymph nodes on the same side of the chest. It can be treated with a single radiation field.
Extensive stage: The cancer has spread beyond one lung, involving other parts of the body, and cannot be treated with a single radiation field.
The non-small cell lung cancer stages include:
Stage 0: The cancer is found only in a few layers of cells and has not grown deeper into the lung tissue or spread to lymph nodes or distant sites.
Stage I: The cancer is small and has not spread to the lymph nodes or distant sites. It can be divided into:
Stage IA: The tumour is 3 centimetres or smaller.
Stage IB: The tumour is larger than 3 centimetres but still confined to the lung.
Stage II: The cancer is larger or has spread to nearby tissues or lymph nodes but not to distant sites. It can be divided into:
Stage IIA: The tumour is larger than 3 centimetres but less than 5 centimetres, or it has spread to several nearby lymph nodes.
Stage IIB: The tumour is larger than 5 centimetres or has spread to more nearby lymph nodes.
Stage III: The cancer has spread to the lymph nodes on the same side of the chest or to nearby tissues but not to distant sites. It can be divided into:
Stage IIIA: The cancer has spread to nearby lymph nodes but remains localised to one side of the chest.
Stage IIIB: The cancer has spread more extensively to nearby structures or lymph nodes, which may include the mediastinum (the area between the lungs) or the chest wall.
Stage IV: The cancer has spread to both lungs, the area around the lungs, or distant organs such as the brain, bones, or liver.
Lung cancer develops when cells in the lungs grow uncontrollably, forming tumours that can interfere with normal lung function. The leading causes for lung cancer include:
Smoking: Cigarette smoking is the primary cause of lung cancer. The risk increases with the number of cigarettes smoked and the duration of smoking.
Secondhand smoke: Non-smokers exposed to secondhand smoke (environmental tobacco smoke) have an increased risk of developing lung cancer.
Radon exposure: Radon, a radioactive gas that can accumulate in buildings, is the second leading cause of lung cancer, especially among non-smokers.
Carcinogen exposure: Exposure to asbestos, arsenic, chromium, nickel, and other carcinogenic substances, particularly in occupational settings, can increase the risk of lung cancer.
Air pollution: Exposure to outdoor air pollution, such as particulate matter and diesel exhaust, has been linked to an increased risk of lung cancer.
Family history and genetic factors: Having a family history of lung cancer or certain genetic mutations may increase an individual's risk of developing the disease.
Several factors can increase the risk of developing lung cancer, including:
Smoking
Secondhand smoke exposure
Radon exposure
Exposure to certain workplace substances such as asbestos, arsenic, chromium, nickel, and diesel exhaust
Previous radiation therapy
Family history
Air pollution
High levels of arsenic in drinking water
Lung cancer can lead to various complications that significantly affect a patient’s health and quality of life. These include:
Metastases: Metastases occur when lung cancer spreads to other organs like the brain, liver, or bones, leading to new symptoms and requiring additional treatments such as chemotherapy or targeted therapies.
Respiratory issues: Lung cancer can cause persistent cough, shortness of breath, and increased pneumonia risk due to airway obstruction or compromised lung function, often necessitating treatments like supplemental oxygen.
Pleural effusion: Pleural effusion involves fluid buildup in the pleural space, causing discomfort and breathing difficulties. It may require medical intervention to drain the fluid and alleviate symptoms.
Superior vena cava syndrome: This syndrome arises when a tumour compresses the superior vena cava, causing facial and neck swelling, shortness of breath, and dizziness.
Chronic pain: Chronic pain may develop from lung cancer or its treatments. Effective management is essential for quality of life and may involve medications, physical therapy, and palliative care.
Psychological effects: The emotional impact of lung cancer can lead to anxiety and depression. Support from mental health professionals, counselling, or support groups is important for coping with these challenges.
While not all cases of lung cancer can be prevented, there are several steps individuals can take to reduce their risk. These include:
Avoiding tobacco use: The most effective prevention method is avoiding all forms of tobacco. Quitting smoking significantly reduces lung cancer risk.
Reducing exposure to secondhand smoke: Limiting exposure to secondhand smoke is essential. Avoiding environments where smoking occurs helps decrease risk, particularly for non-smokers and children.
Healthy lifestyle choices: A balanced diet rich in fruits and vegetables, regular physical activity, and effective weight management strengthen the immune system and lower cancer risk.
Environmental awareness: Reducing exposure to environmental toxins, such as radon and asbestos, is crucial. Testing homes for radon and ensuring proper ventilation can mitigate these risks.
Regular health screenings: High-risk individuals, like long-term smokers, should consider regular screenings such as low-dose CT scans for early detection, which can improve treatment outcomes.
Vaccination: Vaccines for infections like human papillomavirus (HPV) and hepatitis B virus (HBV), while not directly linked to lung cancer, play a role in overall cancer prevention.
If a person experiences symptoms suggestive of lung cancer, their doctor may recommend several tests to diagnose the condition. These include:
Chest X-ray: A chest X-ray is often the initial test, revealing abnormal masses or nodules that may indicate the presence of cancer.
Computed tomography scan: A computed tomography (CT) scan provides more detailed images, helping to determine the size and location of tumours, as well as whether they have spread to nearby lymph nodes.
Sputum cytology: In some cases, a sample of mucus (sputum) may be examined under a microscope to check for cancer cells. This test is particularly effective for detecting tumours located within the airways.
Biopsy: A biopsy is crucial for confirming a lung cancer diagnosis. Methods include a needle biopsy, where a thin needle collects tissue through the skin, and bronchoscopy, which uses a thin tube with a camera to obtain samples from the lungs. In more complex cases, a surgical biopsy may be needed to secure a larger tissue sample.
Molecular testing: Once cancer is diagnosed, molecular testing may be conducted on the biopsy sample to identify specific genetic mutations. This information can guide targeted therapy options tailored to the patient’s cancer profile.
Positron emission tomography scan: A positron emission tomography (PET) scan is an imaging test that helps stage lung cancer by identifying metastases. It provides detailed images of metabolic activity, revealing areas where cancer cells may be active, which aids in treatment planning.
Mediastinoscopy: Mediastinoscopy is a minimally invasive procedure used to examine the mediastinum, the area between the lungs. It assesses lymph node involvement and allows for tissue sampling, which is crucial for staging lung cancer and guiding treatment decisions.
The treatment and management of lung cancer depend on various factors, including the type and stage of cancer and the patient’s overall health. Common treatment options include:
Surgery: Surgery aims to remove the tumour and surrounding tissue. It is often considered for early-stage lung cancer. The type of surgery can vary from a lobectomy (removal of a lobe of the lung) to a pneumonectomy (removal of an entire lung).
Radiation therapy: Radiation therapy uses high-energy rays to kill cancer cells or shrink tumours. It may be used as a primary treatment, after surgery to eliminate remaining cancer cells, or for palliative care to relieve symptoms.
Chemotherapy: Chemotherapy involves the use of medicines to kill cancer cells or stop their growth. It can be administered before surgery (neoadjuvant therapy) to shrink tumours or after surgery (adjuvant therapy) to reduce the risk of recurrence. Chemotherapy may also be used for advanced stages of lung cancer.
Targeted therapy: Targeted therapy focusses on specific genetic mutations or abnormalities within cancer cells. This treatment is often used for non-small cell lung cancer (NSCLC) that has certain markers, allowing for a more personalised approach.
Immunotherapy: Immunotherapy boosts the body’s immune system to fight cancer. It is increasingly used for advanced lung cancer and can lead to long-lasting responses in some patients.
Palliative care: Palliative care focusses on improving the quality of life for patients with lung cancer, addressing symptoms like pain, breathlessness, and emotional distress.
Living with lung cancer presents numerous challenges, but with the right strategies and support, individuals can manage their condition and maintain a better quality of life. Here are few points to consider:
Quitting smoking is highly recommended before starting treatment for lung cancer, as it can improve treatment outcomes and reduce side effects such as breathlessness.
Managing symptoms like shortness of breath, pain, and fatigue is essential.
Treatments such as supplemental oxygen, medications, and palliative care can help improve quality of life.
Maintaining a healthy diet and engaging in regular physical activity, as tolerated, can help improve overall well-being and reduce fatigue.
Seeking emotional support from family, friends, or support groups can help cope with the challenges of living with lung cancer.
Regularly communicating with the doctor about any new or worsening symptoms is crucial for timely intervention and management.
If you experience any symptoms that may indicate lung cancer, such as persistent cough, chest pain, shortness of breath, unexplained weight loss, or coughing up blood, it is crucial to consult a doctor promptly. Additionally, if you are undergoing treatment for lung cancer and experience any new or worsening symptoms, such as severe pain, difficulty breathing, or sudden changes in your health status, it is essential to contact your doctor immediately.
Lung cancer treatment depends on factors such as the type and stage of the cancer and the patient's overall health.
Treatment options for lung cancer include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy.
Living with lung cancer involves making lifestyle changes, such as quitting smoking and managing symptoms, to improve quality of life.
Seeking emotional support and maintaining open communication with the doctor are essential for coping with lung cancer.
Early detection and prompt medical attention for concerning symptoms can significantly improve treatment outcomes and survival rates for lung cancer.
Survival rates for lung cancer vary depending on the stage at diagnosis, cancer type, and overall health, with early detection significantly improving outcomes.
Stage 4 lung cancer is the most advanced stage, characterised by the spread of cancer to distant parts of the body, such as the brain or bones.
Early lung cancer may not cause noticeable symptoms. When present, symptoms can include persistent cough, coughing up blood, chest pain, hoarseness, weight loss, and fatigue.
Lung cancer typically starts when abnormal cells in the lungs grow uncontrollably, often triggered by genetic mutations caused by smoking, carcinogen exposure, or genetic predisposition.
Stage 1 lung cancer is often asymptomatic or presents with mild symptoms like persistent cough, coughing up blood, chest pain, or hoarseness.
Lung cancer growth rate varies by individual and cancer type, with small cell lung cancer generally spreading more rapidly than non-small cell lung cancer.
Lung cancer can cause pain, particularly in later stages, often felt in the chest, back, or shoulders, and worsening with coughing or deep breathing.
The final stage of cancer, known as stage 4 or advanced cancer, is when the cancer has spread to distant parts of the body.
Long-term survival with lung cancer depends on factors like the stage at diagnosis and the effectiveness of treatment. Early-stage lung cancer has better survival rates.
Non-smokers may develop lung cancer due to factors such as exposure to secondhand smoke, radon, asbestos, air pollution, or genetic predisposition.
Lung cancer can affect a person's life in many ways, including physical symptoms, emotional distress, financial burden, and changes in daily activities and relationships.
American Cancer Society. (2021). Lung cancer stages. https://www.cancer.org/cancer/lung-cancer/detection-diagnosis-staging/staging.html
American Lung Association. (2020). Lung cancer basics. https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/basics
National Cancer Institute. (2021). Non-small cell lung cancer treatment (PDQ®)–Patient version. https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq
Centers for Disease Control and Prevention. (2021). Lung cancer. https://www.cdc.gov/cancer/lung/
...View more
...View more
Subscribe
Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.
Download Truemeds
Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v3.4.16
Our Payment Partners